Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:28 PM
Ignite Modification Date:
2025-12-24 @ 9:28 PM
NCT ID:
NCT02433132
Eligibility Criteria:
Inclusion Criteria:
* For patients with cystic fibrosis and those with atypical form:
• Inclusion at least 30 days after a general or local infection of the upper airways
* For controls:
• No history or Sino-pulmonary pathology and negative identification of mutations in the CFTR gene
* For all subjects involved in research:
* Information and obtaining informed consent of the subjects.
* Age ≥ 18 years
* affiliation to a social security scheme or of such a regime
Exclusion Criteria:
* For all participants :
* Taking a per os corticoids or topical corticosteroid treatment in the nose in the month preceding the nasal brushing or measurement of nasal potential difference
* ORL surgical history of under 2 months
* cauterization of the inferior turbinate of under 2 months
* Hypersensitivity to local anesthetics of the amide (such as lidocaine) or with one of the components, including methyl parahydroxybenzoate contained in the excipient.
* Porphyria.
* Epilepsy not controlled by treatment.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02433132
Study Brief:
Protocol Section:
NCT02433132